Dementias & Alzheimer’s

In-Silico-Designed Protein Probes May Diagnose Neurodegenerative Diseases Earlier

Researchers designed in silico “molecular probes” able to track the progress of a protein that misbehaves in neurodegenerative diseases.

Dementias & Alzheimer’s

Alzheimer’s Biomarker Can Predict Postoperative Delirium

Clinical studies have demonstrated a strong association between Alzheimer’s disease (AD) and postoperative delirium.

Dementias & Alzheimer’s

Albert Einstein College of Medicine Gets $4.2M Grant to Find Alzheimer’s Behavioral Markers

Researchers at Albert Einstein College of Medicine have been awarded a $4.2 million NIH grant to detect behavioral markers for Alzheimer’s.

Diadem’s Early Alzheimer’s Prediction Test Gets CE-IVD Certification

Mar 1, 2022 | Dementias & Alzheimer’s

Diadem Srl today announced CE IVD certification for its AlzoSure Predict prognostic blood test for the early prediction of Alzheimer’s disease.

New Alzheimer’s Blood Test Achieves High Accuracy in Large Study

Feb 25, 2022 | Dementias & Alzheimer’s

The study showed that the blood test provides a robust measure for detecting amyloid plaques associated with Alzheimer’s disease.

Petri-Dish Substrate Innovation to Aid Neurological Disorder Testing

Feb 22, 2022 | Dementias & Alzheimer’s

Scientists teamed up on the petri-dish innovation to be able to grow and age live brain cells from patients with neurological disorders.

Human Olfactory Mucosa Cell Model May Improve Alzheimer’s Disease Diagnosis

Feb 16, 2022 | Dementias & Alzheimer’s

Researchers have developed a new cell model for Alzheimer’s that has wide utility for research and could help in early diagnosis and testing.

Eye Test May Help Diagnose Alzheimer’s Earlier

Feb 11, 2022 | Dementias & Alzheimer’s

A simple eye test may make it easier to diagnose some degenerative diseases much earlier, researchers say.

Multi-Year Brain Study Aims to Diagnose, Prevent Neurological Diseases Early

Jan 20, 2022 | Dementias & Alzheimer’s

Cleveland Clinic launched an in-depth study to better understand the cause of certain brain diseases, with the goal of pinpointing disease biomarkers early.

Brain Cell Damage Markers Higher in COVID Patients than Alzheimer’s Patients

Jan 14, 2022 | Covid 19, Dementias & Alzheimer’s

The new study found higher levels of seven markers of brain damage in COVID-19 patients with neurological symptoms than those without them.

An Alzheimer’s Disease Risk Factor May Predispose Carriers to Severe COVID-19

Jan 5, 2022 | Covid 19, Dementias & Alzheimer’s

Researchers have reported observations that show a link between APOE4 and COVID-19, in terms of susceptibility to SARS-CoV-2 infection and mortality.

Redefining State-of-the-Art Diagnostic Technologies for Alzheimer’s Detection

Dec 24, 2021 | Dementias & Alzheimer’s

New approaches and technologies are providing an array of tools to identify Alzheimer’s disease in its earliest stages.

Researchers to Aim to Use New Blood Test to Prevent Memory Loss

Nov 24, 2021 | Dementias & Alzheimer’s

Research indicates a blood test can be used to identify people with an increased likelihood of having brain amyloid.

MYND Diagnostics Researching Alzheimer’s Biomarker

Nov 19, 2021 | Dementias & Alzheimer’s

MYND Diagnostics began clinical research on a new test for diagnosing and monitoring Alzheimer’s Disease via an anti-inflammatory peptide biomarker.

Increased Fats and Protein Linked to Lewy Body Dementia

Nov 10, 2021 | Dementias & Alzheimer’s

Increased levels of certain fats and proteins found in Lewy body dementia could help with diagnosis and testing for the effectiveness of treatments.

Researchers Find Biomarker for Dementia

Oct 25, 2021 | Dementias & Alzheimer’s

Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules in the blood that can indicate impending dementia.